- Synthetic biology
- Metabolic engineering
- Bio-based molecules
- Sustainable development
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.Discover >
Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.Discover >
Development of custom-order microorganisms able to produce molecules of interest in health, nutrition, cosmetics, chemistry and agriculture.
Abolis merges bioinformatic, genetic and robotic processes to redesign metabolic pathways. With its technology, the company creates industrial microbial strains capable of producing molecules of interest via fermentation.
The underlying concept is to harness and improve upon natural biosynthesis processes.
DESCRIPTION OF THE PRODUCTS / SERVICES /TECHNOLOGY
With its synthetic biology platform, Abolis reliably provides businesses with the existing or novel molecules they need while maintaining sustainability (bio-based and biodegradable materials) and significantly reducing the environmental impact of molecular production. Abolis contributes to all project phases: from initial study, to intellectual property protection and on through to industrialization.
ACCOMPLISHMENTS / COLLABORATIONS / HIGHLIGHTS
In 2014 Abolis Biotechnologies was a start-up phase laureate of the Innovation 2030 Worldwide Innovation Challenge. Abolis has partnerships with such groups as Lesaffre and Givaudan and has filed six patents.
Abolis pursues its own research program.
In parallel, the company establishes industrial partnerships to:
In same field
Fabmid develop a cutting-edge DNA vector to reduce the cost and improve efficiency of cell and gene therapyDiscover
Production as a service (PaaS) platform capable of producing recombinant proteins & enzymes cheaper and on a scale.Discover
Altar is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.Discover
YposKesi is the first French company to develop and manufacture gene and cell therapy products for rare diseases.Discover
WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.Discover
R & D services in the field of transient expression of recombinant proteins in plants.Discover
Pharming specializes in the production of recombinant proteins in transgenic rabbit milk.Discover
Glowee is a cleantech startup developing a disruptive lighting technology based on bioluminescence (the natural light-producing property of certain living organisms).Discover
Global Bioenergies is developing a process to convert renewable resources into hydrocarbons through fermentation.Discover